Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models (Q36448521)

14 August 2017

1 reference

title

Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models (English)

1 reference

14 August 2017

3

Mathias Jucker

1 reference

14 August 2017

Martin C Herzig

1

1 reference

PubMed ID

16612981

14 August 2017

William E Van Nostrand

series ordinal

2

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

16

1 reference

14 August 2017

1

1 reference

14 August 2017

40-54

1 reference

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Immunotherapy for Alzheimer's disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Expression of human beta-secretase in the mouse brain increases the steady-state level of beta-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A vector for expressing foreign genes in the brains and hearts of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Overexpression of growth-associated proteins in the neurons of adult transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti-Abeta antibody into the third ventricle of TgCRND8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Solvent and mutation effects on the nucleation of amyloid beta-protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Biogenesis and metabolism of Alzheimer's disease Abeta amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral microvascular pathology in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy and vessel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid angiopathy-related vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Metabolism of amyloid-beta peptide and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Metabolic regulation of brain Abeta by neprilysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Abeta does not induce oxidative stress in human cerebrovascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

On the nucleation of amyloid beta-protein monomer folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Hereditary cerebral hemorrhage with amyloidosis-Dutch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Review: modulating factors in amyloid-beta fibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Extracellular amyloid formation and associated pathology in neural grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

LRP-mediated clearance of Abeta is inhibited by KPI-containing isoforms of APP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

SDS-stable complex formation between native apolipoprotein E3 and beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Anti-angiogenic activity of the mutant Dutch A(beta) peptide on human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The other "closest living relative". How bonobos (Pan paniscus) challenge traditional assumptions about females, dominance, intra- and intersexual interactions, and hominid evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Inhibition of angiogenesis by Abeta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Inhibition of amyloid-beta-induced cell death in human brain pericytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A beta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Molecular biology of apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amyloid beta peptide in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Pathological Studies on Cerebral Amyloid Angiopathy, Senile Plaques and Amyloid Deposition in Visceral Organs in Aged Dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid in the brains of aged squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

The origin of amyloid in cerebral vessels of aged dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Cerebral amyloid angiopathy: both viper and maggot in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Is Alzheimer's disease an apolipoprotein E amyloidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Association of neprilysin polymorphism with cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

LRP and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2006.TB00560.X

10.1111/J.1750-3639.2006.TB00560.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16612981